Zhejiang Yatai Pharmaceutical News

Asia Pacific Pharmaceutical: Notice on the Company\'s Obtaining a Notice of Approval of the Drug Supplement Application

Dec 14 00:00

Asia Pacific Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024

Dec 12 00:00

Asia Pacific Pharmaceutical: Announcement on the termination of the convertible bond fund-raising investment project

Dec 12 00:00

Asia Pacific Pharmaceutical: Announcement on the cumulative amount of debt-for-equity swaps of Asia Pharmaceuticals reaching 10% of the total amount of shares issued by the company before the share conversion

Dec 12 00:00

Asia Pacific Pharmaceutical: China Investment Securities Co., Ltd.\'s verification opinion on Zhejiang Asia Pacific Pharmaceutical Co., Ltd. terminating a fund-raising investment project with convertible bonds

Dec 12 00:00

Asia Pacific Pharmaceutical: Announcement on the cumulative amount of debt-for-equity swaps of Asia Pharmaceuticals reaching 10% of the total amount of shares issued by the company before the share conversion

Dec 10 00:00

Asia Pacific Pharmaceutical: Progress Announcement on Wholly-owned Subsidiaries Providing Guarantees for the Company\'s Financing

Dec 7 00:00

Asia Pacific Pharmaceuticals: Notice on Receipt of Civil Judgment

Dec 5 00:00

Asia Pacific Pharmaceutical: Announcement on the freezing of the company\'s bank account

Dec 5 00:00

Asia Pacific Pharmaceutical: Notice on receiving the acceptance notice for the consistency evaluation of diltiazem hydrochloride tablets

Nov 29 00:00

Asia Pacific Pharmaceutical: Announcement on Atomic Company\'s completion of the registration of capital reduction and commercial changes

Nov 12 00:00

Asia Pacific Pharmaceutical: Announcement on the progress of liquidation and cancellation of joint ventures

Nov 1 00:00

Asia Pacific Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024

Oct 9 00:00

Asia Pacific Pharmaceutical: Announcement on Sale of 100% Shares in Wholly-owned Subsidiaries and Debt Forgiveness

Sep 10 00:00

Asia Pacific Pharmaceutical: Progress Notice on Litigation Matters

Sep 10 00:00

Asia Pacific Pharmaceutical: Notice on receiving the acceptance notice for the consistency evaluation of atenolol tablets

Sep 7 00:00

Zhejiang Yatai Pharmaceutical: Financial Report for the first half of 2024.

Aug 24 00:00

Zhejiang Yatai Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.

Aug 24 00:00

Zhejiang Yatai Pharmaceutical: Announcement Regarding Not Lowering the Conversion Price of Yayao Convertible Bonds to Equity

Jul 26 00:00

Zhejiang Yatai Pharmaceutical: Announcement on changing the continuously supervised sponsoring representative.

Jul 26 00:00